Factors Associated with HIV Viral Suppression Among Transgender Women in Lima, Peru. 2018

Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
1 AIDS Program, Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut.

OBJECTIVE Globally, transgender women (TGW) experience a high burden of adverse health outcomes, including a high prevalence of HIV and sexually transmitted infections (STIs) as well as psychiatric disorders and substance use disorders. To address gaps in HIV research in Peru focused specifically on TGW, this study presents characteristics of a sample of HIV-positive TGW and identifies factors associated with viral suppression. METHODS Between June 2015 and August 2016, 50 HIV-positive TGW were recruited in Lima, Peru. Multivariable logistic regression was used to identify factors associated with viral suppression (<200 copies/mL) among the TGW. RESULTS Among TGW, 85% achieved viral suppression. Approximately half (54%) reported anal sex with more than five partners in the past 6 months, 38% reported sex work, 68% had not disclosed their HIV status to one or more of their partners, and 38% reported condomless sex with their last partner. The prevalence of alcohol use disorders was high (54%), and 38% reported use of drugs in the past year. Moderate-to-severe drug use significantly reduced odds of achieving viral suppression (adjusted odds ratio 0.69; 95% confidence interval: 0.48-0.98). CONCLUSIONS Our findings highlight the need for integrated treatment for substance disorders in HIV care to increase the viral suppression rate among TGW in Lima, Peru.

UI MeSH Term Description Entries
D008297 Male Males
D010568 Peru A country in western South America, bordering the South Pacific Ocean, and located between Chile and Ecuador.
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006297 Health Services Accessibility The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others. Access To Care, Health,Access to Care,Access to Contraception,Access to Health Care,Access to Health Services,Access to Medications,Access to Medicines,Access to Therapy,Access to Treatment,Accessibility of Health Services,Availability of Health Services,Contraception Access,Contraceptive Access,Medication Access,Accessibility, Health Services,Contraceptive Availability,Health Services Geographic Accessibility,Program Accessibility,Access to Cares,Access to Contraceptions,Access to Medication,Access to Medicine,Access to Therapies,Access to Treatments,Access, Contraception,Access, Contraceptive,Access, Medication,Accessibilities, Health Services,Accessibility, Program,Availability, Contraceptive,Care, Access to,Cares, Access to,Contraception, Access to,Contraceptive Accesses,Health Services Availability,Medication Accesses,Medication, Access to,Medicine, Access to,Medicines, Access to,Therapy, Access to,Treatment, Access to
D006301 Health Services Needs and Demand Health services required by a population or community as well as the health services that the population or community is able and willing to pay for. Health Services Needs,Needs,Needs and Demand, Health Services,Target Population,Health Services Need,Need, Health Services,Needs, Health Services,Population, Target,Populations, Target,Target Populations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
March 2025, Journal of acquired immune deficiency syndromes (1999),
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
September 2025, AIDS (London, England),
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
January 2017, AIDS and behavior,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
January 2021, The journal of applied laboratory medicine,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
August 2017, AIDS and behavior,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
November 2019, Journal of the International AIDS Society,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
February 2017, Journal of the International AIDS Society,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
October 2019, LGBT health,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
January 2018, PloS one,
Katherine M Rich, and Jeffrey A Wickersham, and Javier Valencia Huamaní, and Sara N Kiani, and Robinson Cabello, and Paul Elish, and Jorge Florez Arce, and Lia N Pizzicato, and Jaime Soria, and Jorge Sanchez, and Frederick L Altice
August 2015, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!